Skip to main content
OpenTrials

Clinical trial condition

Vision Disorders

Explore clinical trials studying Vision Disorders. Study availability and eligibility vary by location and protocol.

263 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Vision Disorders trial results

Completed

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

NCT04264819

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 51 locations
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

NCT04964089

Conditions
Eye Diseases, Eye Diseases, Hereditary, Macular Degeneration, +10 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Northwest Arkansas Retina Associates Springdale, Arkansas, United States
  • California Retina Consultants Bakersfield, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 66 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT04592419

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +16 more
Locations
  • Northwest Arkansas Retina Associates Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Vitreous Associates Beverly Hills, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 141 locations
View Trial Details
Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Rancho Cordova, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site ‘Aiea, Hawaii, United States
View all 22 locations
View Trial Details

Related conditions